Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-19816

Handschin, C (2009). The biology of PGC-1alpha and its therapeutic potential. Trends in Pharmacological Sciences, 30(6):322-329.

Accepted Version


In eukaryotes, cellular and systemic metabolism is
primarily controlled by mitochondrial activity. The peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) is an important regulator of mitochondrial biogenesis and function. Furthermore, PGC-1alpha controls many of the phenotypic adaptations of oxidative tissues to external and internal perturbations. By contrast, dysregulated metabolic plasticity is involved in the etiology of numerous diseases. Accordingly, modulation of PGC-1alpha levels and activity has recently been proposed as a therapeutic option for several pathologies. However, pharmacological interventions aimed at PGC-1alpha have to overcome inherent limitations of targeting a coactivator protein. Here, I focus on the recent breakthroughs in the identification of physiological and pathophysiological contexts involving PGC-1alpha. In addition, perspectives regarding the therapeutic importance of PGC-1alpha controlled cellular and systemic metabolism are outlined.

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > Institute of Physiology
07 Faculty of Science > Institute of Physiology
DDC:570 Life sciences; biology
610 Medicine & health
Date:14 May 2009
Deposited On:21 Jul 2009 13:13
Last Modified:27 Nov 2013 19:57
Publisher DOI:10.1016/j.tips.2009.03.006
PubMed ID:19446346
Citations:Web of Science®. Times Cited: 38
Google Scholar™
Scopus®. Citation Count: 45

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page